PROCEDURE · Unmapped registry intervention
Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)
Find medicine records ·
Find other trials using this name
Clinical trial
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
NCT04326036
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DEVICE · Unmapped registry intervention
Centricyte 1000
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
IV Deployment Of cSVF In Sterile Normal Saline IV Solution
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Liberase Enzyme (Roche)
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Sterile Normal Saline for Intravenous Use
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedUse of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: EARLY_PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Idiopathic Pulmonary Fibrosisunresolved
Viral Pneumoniaverified · MONDO: viral pneumonia
Coronavirus Infectionunresolved
Interventions
Sponsors & collaborators
Black Tie Medical, Inc.lead sponsor
Alexander, Robert W., M.D.collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04326036 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.